US2012258879A1PendingUtilityA1
Polymorphism Detection
Est. expiryNov 29, 2015(expired)· nominal 20-yr term from priority
G16B 25/00C07H 21/04B01J 2219/00626C12Q 1/6874C40B 40/06B82Y 30/00B01J 2219/00659B01J 2219/00608B01J 2219/00722B01J 2219/00711C40B 60/14Y10T436/143333G16B 30/00B01J 2219/00432C12Q 1/6827
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention generally provides a rapid efficient method for analyzing polymorphic or biallelic markers, and arrays for carrying out these analyses. In general, the methods of the present invention employ arrays of oligonucleotide probes that are complementary to target nucleic acids which correspond to the marker sequences of an individual. The probes are typically arranged in detection blocks, each block being capable of discriminating the three genotypes for a given marker, i.e., the heterozygote or either of the two homozygotes. The method allows for rapid, automatable analysis of genetic linkage to even complex polygenic traits
Claims
exact text as granted — not AI-modified1 . An array of oligonucleotide probes for detecting a polymorphism in a target nucleic acid sequence using principal component analysis, said array comprising at least one detection block of probes, said detection block including a first group of probes that are complementary to said target nucleic acid sequence except that the group of probes includes all possible monosubstitutions of positions in said sequence that are within n bases of a base in said sequence that is complementary to said polymorphism, wherein n is from 0 to 5, and a second and third group of probes complementary to marker-specific regions upstream and downstream of the target nucleic acid sequence, wherein the third group of probes differs from the second set of probes at single bases corresponding to known mismatch positions:
2 . The array of claim 1 , wherein the polymorphism is identified as a result of Principal Component Analysis of hybridization intensities of the array of probes.
3 . The array of claim 1 , wherein at least two alleles of the polymorphism are known.
4 . The array of claim 1 , wherein said first group of probes comprises a plurality of different probes that are complementary to overlapping portions of said target nucleic acid sequence.
5 . The array of claim 1 , wherein the monosubstitutions occur at a plurality of distances from a 3′ end of said probes.
6 . The array of claim 1 , wherein said detection block includes between about 8 and 88 different probes.
7 . The array of claim 1 , comprising between 1 and 1,000 different detection blocks, each of said detection blocks including probes complementary to different polymorphisms in said target nucleic acid sequence.
8 . A method of identifying whether a target nucleic acid sequence includes a polymorphic variant using principal component analysis, comprising:
hybridizing said target nucleic acid sequence to said array comprising at least one detection block of probes, said detection block including a first group of probes that are complementary to said target nucleic acid sequence except that the group of probes includes all possible monosubstitutions of positions in said sequence that are within n bases of a base in said sequence that is complementary to said polymorphism, wherein n is from 0 to 5, and a second and third group of probes complementary to marker-specific regions upstream and downstream of the target nucleic acid sequence, wherein the third group of probes differs from the second set of probes at single bases corresponding to known mismatch positions, and determining hybridization intensities of the target nucleic acid and the marker-specific regions to identify said polymorphic variant.
9 . The method of claim 8 , wherein said target nucleic acid comprises a detectable label.
10 . The method of claim 9 , wherein said detectable label is a fluorescent group.
11 . The method of claim 9 , wherein said label is a binding group.
12 . The method of claim 11 , wherein said binding group is selected from biotin, avidin and streptavidin.
13 . The method of claim 8 , wherein the polymorphism is identified as a result of Principal Component Analysis of hybridization intensities of the array of probes.
14 . The method of claim 8 , wherein at least two alleles of the polymorphism are known.
15 . The method of claim 8 , wherein said step of determining comprises
a) calculating the control difference between the average of the hybridization intensities of the second group of probes, the hybridization intensities comprising control perfect matches (PM), minus the average of the hybridization intensities, the hybridization intensities comprising control single-base mismatches (MM), b) calculating the possible perfect match intensity and a heteromismatch intensity from the hybridization intensities for each position of monosubstitutions of the first group of probes; c) calculating the difference between the possible perfect match intensity and the heteromismatch intensity for each position of monosubstitutions of the first group of probes; d) calculating a normalized difference (ND) by dividing the difference of step (c) by the control difference; (e) using principal component analysis, identifying a polymorphism by comparing normalized differences between individuals in a population.
16 . The method of claim 15 , wherein an ND is calculated for at least two allele of a polymorphism.
17 . The method of claim 16 , wherein homozygotes and heterozygotes are detected by combining principal component analysis for two alleles.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.